Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma.

Published in: Scandinavian journal of gastroenterology (2019)

Galectin 4 expression is a novel biomarker for early recurrence and mortality after surgical resection for pancreatic cancer.

Keyphrases